RLAY
Relay Therapeutics Inc
NASDAQ: RLAY · HEALTHCARE · BIOTECHNOLOGY
$12.57
-3.53% today
Updated 2026-04-29
Market cap
$2.41B
P/E ratio
—
P/S ratio
156.64x
EPS (TTM)
$-1.61
Dividend yield
—
52W range
$3 – $17
Volume
3.0M
Relay Therapeutics Inc (RLAY) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-899.00%
ROE
-41.10%
ROA
-25.40%
Debt/equity
0.05x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2018 | $0.00 | $-48.78M | — | — | — |
| 2019 | $0.00 | $-66.50M | — | — | — |
| 2020 | $82.65M | $-52.41M | 95.71% | -67.51% | -63.41% |
| 2021 | $3.03M | $-363.87M | 100.00% | -12,040.21% | -12,012.94% |
| 2022 | $1.38M | $-290.51M | 100.00% | -21,670.89% | -21,036.13% |
| 2023 | $25.55M | $-341.97M | 100.00% | -1,460.11% | -1,338.66% |
| 2024 | $10.01M | $-337.71M | 100.00% | -3,722.07% | -3,374.72% |
| 2025 | $15.36M | $-276.48M | 76.83% | -1,971.59% | -1,800.58% |